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Abstract: (200 words) 
Understanding multi-host pathogen maintenance and transmission dynamics is critical for 
disease control. However, transmission dynamics remain enigmatic largely because they are 
difficult to observe directly, particularly in wildlife. Here, we investigate the transmission 
dynamics of canine parvovirus (CPV) using state-space modelling of 20-years of CPV serology 
data from domestic dogs and African lions in the Serengeti ecosystem. We show that, although 
vaccination reduces the probability of infection in dogs, and despite indirect enhancement of 
population seropositivity as a result of vaccine shedding, the vaccination coverage achieved 
has been insufficient to prevent CPV from becoming widespread. CPV is maintained by the 
dog population and has become endemic with ~3.5-year cycles and prevalence reaching ~80%.  
While the estimated prevalence in lions is lower, peaks of infection consistently follow those 
in dogs. Dogs exposed to CPV are also more likely to become infected with a second multi-
host pathogen, canine distemper virus. However, vaccination can weaken this coupling raising 
questions about the value of monovalent versus polyvalent vaccines against these two 
pathogens. Our findings highlight the need to consider both pathogen- and host-level 
community interactions when seeking to understand the dynamics of multi-host pathogens and 
their implications for conservation, disease surveillance and control programmes. 
 
Keywords: State-space models, longitudinal serology, coinfection, domestic-wildlife 
interface, maintenance host, vaccine shedding 
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Introduction 
Pathogens that can be transmitted between multiple host species pose challenges for disease 
control [1,2]. For example, multi-host pathogens can persist in ecologically complex multi-
species metapopulations that may serve as either maintenance or non-maintenance populations, 
contributing differentially to pathogen persistence, and requiring different approaches to 
control [1,3]. Identifying the maintenance host population of a pathogen and unravelling the 
transmission dynamics among different populations is therefore critical for effective control. 
However, our understanding of multihost pathogens, particularly in wildlife, is often poor 
because epidemiological processes such as infection, clinical progression, morbidity and 
mortality are difficult to observe, necessitating less direct sources of inference. When it is 
possible to isolate pathogen genetic material from infected hosts, phylodynamic analyses can 
provide a rich source of insight (e.g. as for canine and bat rabies [4–6]).  However, obtaining 
pathogen genetic material can be difficult, especially for pathogens that infect wildlife, for 
those that cause short-lived infections or are associated with low mortality rates that may 
therefore go undetected. A common alternative source of information is serological data. 
Serology can be used to infer if an individual has been exposed to infection [7]. However, using 
this type of data to make inferences about within- and between-species dynamics is challenging 
and requires sophisticated statistically rigorous methodology (e.g. as for canine distemper and 
rinderpest viruses [8,9]). Here, we use serological data to identify the maintenance population 
and reveal the transmission dynamics of canine parvovirus (CPV) in a complex multi-host, 
multi-pathogen environment [10–14]. 
 
CPV is a highly contagious DNA virus of the family Parvoviridae [15] that can cause vomiting, 
bloody diarrhoea, fever and anorexia in dogs, often leading to death. It was first isolated in the 
late 1970s [16] but has since become a widespread virus infecting domestic and wild canids 
worldwide [17–19]. CPV maintenance is enhanced by multiple factors, likely including 
multiple hosts capable of being infected and transmitting virus through different routes [22].  
It is mainly transmitted by the faecal-oral route [23], but direct contact or environmental 
contamination may also play a role [22]. 
  
CPV is believed to have evolved from the variant Feline Panleukopenia Virus (FPV) 
[18,24,25]. The main consequence of this emergence was a host shift from felids to canids [26] 
with CPV subsequently establishing in dog populations worldwide [17,19,27]. The virus is 
now maintained in many domestic dog populations, often at very high prevalence, e.g. 90% in 
Korea [28], 72% in rural Chile [29]. In domestic dog populations, mortality rates following 
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infection can be as high as 90% in unvaccinated pups [11] but as low as 10% in unvaccinated 
adults [30].  
 
While the domestic dog is now considered to be a primary maintenance host species for CPV, 
the consequences of short-lived epidemic ‘spill overs’ into smaller wildlife host populations 
pose a conservation concern [31,32]. For example, high prevalence has been observed in wild 
canids of vulnerable status such as wolves (Canis lupus) in Spain (62%) [20] and less 
vulnerable status such as red foxes (Vulpes vulpes; 79%) in North America [33]. In North 
American wolves, seropositivity was found to decrease with increasing population sizes and 
proportion of the population that were pups each year [34,35]. Further conservation concerns 
relate to felids. Although CPV may have initially lost its ability to infect and replicate in felids 
[36,37], recent studies have shown that it can now spread efficiently in domestic [38] and wild 
felids including African lions (Panthera leo) [39], puma (Puma concolor), bobcat (Lynx rufus) 
and lynx (L. pardinus) [40]. The cross-species transmission ability of CPV is well known 
mostly from laboratory infection and molecular studies [26,40,41]. However, the dynamics of 
CPV in different hosts and the role of each species in the local maintenance of CPV in natural 
systems remains unclear, especially in environments where a range of susceptible species co-
exist.  
 
Knowledge of the mechanisms of long-term disease maintenance is essential to optimize 
control strategies [1,3]. Vaccination is currently the most effective way to control CPV in dogs 
[11], with 95% survival rates of vaccinated adult dogs following infection challenges [42,43]. 
In the last decade, several dog vaccination programs have been implemented worldwide 
[44,45]. However, in resource-limited areas, vaccination coverage is typically very low. For 
example, in dog populations of Chile, vaccination coverage was reported to be 42% in urban 
areas but only 8% in rural areas [29]. In the Serengeti ecosystem of Tanzania, dog vaccination 
campaigns have been limited to villages in close proximity to wildlife protected areas, covering 
only 5% of the regional dog population in 1996 and reaching a maximum of ~ 30% coverage 
in 2008 [9]. It has been suggested that CPV vaccine in dogs can be shed in the faeces and the 
vaccine virus acquired by susceptible individuals. This has been only recently confirmed by a 
study in the Serengeti demonstrating the presence of vaccine strain sequences in unvaccinated 
dogs [46]. The role of faecal shedding of vaccine in providing unvaccinated animals with 
protection indirectly, potentially increasing herd immunity and the overall efficacy of 
vaccination programmes, is rarely, if ever, assessed. This is largely because serological 
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methods are unable to disentangle natural exposure from indirectly acquired immunization 
(i.e., seropositivity from vaccine shedding). 
 
Well-developed frameworks to conceptualize the epidemiology of multi-host pathogens 
exist, but only recently have we begun to consider the joint epidemiology of multiple 
pathogens that co-occur within the same host [47,48]. Co-infections by multiple pathogens 
are common [49–51] and their interactions may be antagonistic or beneficial to both the host 
and pathogen by modifying transmission efficiency and virulence or by removing hosts from 
a shared susceptible pool [52]. Theory predicts that co-infections can have major 
consequences for both within- and between-host disease dynamics [51,53]. Empirically, this 
remains challenging to prove. Several studies report that CPV co-occurs with other canine 
pathogens, in particular canine distemper virus (CDV) in domestic dog [29,54] and wild 
canid populations [20,55]. Co-circulation of these pathogens is a major reason for the 
widespread use of polyvalent vaccines, for example against CPV, CDV and rabies. However, 
few studies investigate the dynamics of co-circulating canine pathogens. 
 
Previous studies in the Serengeti ecosystem have shown that both CPV and CDV are present 
in domestic dogs [9,56] and lions [39,57]. The dynamics of CDV at the domestic–wildlife 
interface in this system has received attention [9], but little is known about CPV nor its 
interaction with CDV. To unravel these processes, this study uses: a) a large-scale longitudinal 
dataset comprising 29 years (1984-2012) of CPV serology in African lions in the Serengeti 
National Park (SNP) and domestic dogs adjacent to SNP; b) data on regional and village-level 
vaccination against CPV targeting domestic dogs since 1996 [9,58]; and c) CDV serological 
data for the same domestic dogs to investigate CPV and CDV co-exposure dynamics. We use 
Bayesian state-space modelling to integrate these datasets and overcome the challenges of 
using indirect sources of information (i.e. serological data). Ultimately, we aim to confirm the 
maintenance population and identify the transmission dynamics of natural CPV infection by 
(i) disentangling natural from indirectly acquired immunization (vaccine shedding) (ii) 
characterizing the within-host dynamics of natural infection in dogs and lions, and quantifying 
the impact of the dog vaccination programs on those dynamics; (iii) determining the cross-
species transmission dynamics in dogs and lions; and (iv) investigating the co-infection 
dynamics between CPV and CDV in these communities. 
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Methods 
 
Data collection 
Unvaccinated domestic dogs in the northwest of the Serengeti ecosystem (Fig. 1a) were 
sampled from 1992 to 2012. This resulted in a 20-year time-series of domestic dog CPV 
(n=1728) and CDV (n=2368) serological data (Fig. 1b). Because of the possibility of CPV 
vaccination shedding, the dog samples in this study were restricted to villages where 
vaccination coverage was known (n=147 villages). Proxies for vaccination coverage were 
quantified at two levels: a) Regional vaccination coverage (Fig. 1b) estimated annually for the 
region as the proportion of dogs vaccinated in each village averaged across the northwest 
Serengeti ecosystem to the edge of Lake Victoria (including non-vaccinated villages); b) 
Village vaccination coverage (Fig.2a) estimated annually for each village as the proportion of 
dogs vaccinated only in sampled villages. Year of sampling and birth of each dog were also 
available.  
 
Data from lions included CPV serology from individuals sampled between 1984 and 2012 
(n=460) as part of SNP management and research operations (Fig 1). Year of sampling and 
birth were available for each lion. Further sampling details provided in Supplementary 
Information (SI) and [9].  
  
Serological assays 
Lion and dog CPV serology samples collected until 2007 was carried out using 
Haemagglutination Inhibition tests (HAI) and those from 2008 to 2012 were tested using in-
house ELISAs (IgG). CDV neutralisation assays were carried out as previously described [9]. 
For consistency with previous studies, a cut-off titre equivalent to a 1:32 [39] and 1:16 [9] 
dilution was used to define prior exposure to CPV and CDV, respectively. 
 
 
 
Statistical analysis 
Here, we estimate the dynamics and drivers of population-level annual probability of natural 
infection using a Bayesian state-space modelling (SSM) approach. SSMs are useful because 
they comprise two interlinked parts: an observation and a biological process. The former deals 
with the individual-level data (i.e. serology data) to account for both known or suspected biases 
in the data-collection process (e.g. caused by diagnostic testing errors and vaccine shedding). 
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Since serology provides only the immune status at the time of sampling, the timing of infection 
can only be estimated from the serological data in combination with birth and sampling dates 
of each individual. The timing of infection describes the infection dynamics at the population 
level through a linearized predictor comprising several covariates (e.g. time-lags, cross-species 
transmission and vaccination coverage).  
 
Here, the observation process modelled serology data as a Bernoulli trial adjusted with 
sensitivity and specificity terms to account for test diagnostic errors [as in 9]. Further details 
are provided in SI. Critically, because the probability of a dog being seropositive is made up 
of both ‘natural infection’ and the vaccine shedding effect, to disentangle these two processes, 
the logit probability of a dog i being seropositive with CPV (but not CDV) at time t, 
XpCPV,dogs(i,t) was modelled as a function of the vaccine shedding rate (j):  
 
XpCPV,dogs(i,t) =  pCPV,dogs(t) + jVv(i,t)  + eCPV,dogs(i,t)  (1) 
 
The annual probability of CPV natural infection, i.e. that transmitted from unvaccinated dogs, 
pCPV,dogs(t), corresponds to the natural infection at the population level, while j represents the 
rate parameter governing the impact of the village-level vaccination coverage (Vv) on the 
probability of a dog becoming seropositive, i.e. shedding. This prior is based on [46]. The error 
term e enables additional individual uncertainty at time t. All priors are provided in Table S2 
(SI).  
 
Two distinct biological process models were then implemented to describe the dynamics of 
CPV natural infection only, i.e. pCPV,dogs(t) in equation 1: 
 
(i) To estimate the annual probability of CPV natural infection in dogs (pCPV,dogs(t)) and lions 
(pCPV,lions(t)), the logit probability of CPV infection at time t  was described as follows: 
 
pCPV,dogs(t) = [linear predictor] +  v1Vr(t-1) + ΩLD.pCPV,lions(t-1)  (2a) 
pCPV,lions(t) = [linear predictor] + ΩDL.pCPV,dogs(t-1)     (2b) 
 
where [linear predictor] = b0 + b1.t + a1.pCPV(t-1) + a2.pCPV(t-2)   
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The linear predictor describes the baseline dynamics of natural infection, where the coefficient 
b0 represents the intercept and b1 the linear trend over time. The parameters a1 and a2 are 
autocovariates representing time-lags of 1 and 2 years, respectively, and enable the infection 
probability to cycle. The term v1 represents the impact of regional vaccination coverage (Vr) 
lagged by 1 year. The coefficient ΩLD governs the 1-year lagged transmission from lion-to-dog 
and ΩDL from dog-to-lion.  
 
(ii) To investigate the co-exposure pattern between CPV and CDV in dogs we restricted the 
serology time series from 1992 to 2008, as after 2008 all tested samples were CDV negative. 
For the biological process, we first estimated the logit probability of CPV (pCPV,dogs(t), as 
above) and CDV (pCDV,dogs(t)) exposure independently and then together (pboth,dogs(t)) as 
follows: 
 
pCPV,dogs(t) = [linear predictor] + v1Vr(t-1) + d.pCDV,dogs(t-1)   (3a) 
pCDV,dogs(t) = [CDV_linear predictor] + v2Vr(t-1) + l.pCPV,dogs(t-1)   (3b) 
pboth,dogs(t) = Gboth.(pCPV,dogs(t).pCDV,dogs(t)) + GCPV.(pCPV,dogs(t).pCDV,dogs(t-1)) + 
GCDV.(pCPV,dogs(t).pCDV,dogs(t-1)) (3c) 
 
The linear predictors, v1 and v2 are defined as in eq.1. The coefficient d governs the influence 
of CDV on CPV exposure and l governs the influence of CPV on CDV exposure. In eq. 3c, if 
the two diseases have independent dynamics, then the probability of an individual being 
exposed to both is the product pCPV(t).pCDV(t). Then, the probability of being co-exposed 
pboth,dogs is described by three parameters: a) Gboth  which governs the effect of both diseases 
being independent, b) GCPV which governs the effect of CPV on the probability of co-exposure, 
and c) GCDV which governs the effect of CDV on the probability of co-exposure.   
 
The influence of each covariate on co-exposure was also estimated by comparing the full 
prediction with predictions obtained when either the parameter governing the impact of CDV 
on the co-exposure or the parameter governing the impact of CPV on the co-exposure was set 
to zero.  
 
The priors for all parameters are defined in SI (Tables S2-3). All models were fitted in JAGS 
and details of model set-up, convergence and diagnostic assessments are provided in SI. 
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Results 
 
The observed mean CPV seroprevalence in unvaccinated domestic dogs was ~55% across the 
entire time series (Fig. 1b). However, it varied greatly over time with peaks sometimes reaching 
80% seropositivity. The mean CPV seroprevalence observed in lions was similar at ~57% (95% 
CI=0.20-1.00, Fig.1b and Fig. S2 in SI), though the sample size was smaller. 
 
The SSMs used to analyse and quantify specific characteristics of CPV infection dynamics 
converged and fitted well to the data supporting the inferences made. Prior and resultant 
posterior distributions for estimated parameters shown in SI.  
 
Dynamics of CPV and effects of vaccination in domestic dogs  
Our results show that the probability of natural CPV infection in domestic dogs increased at an 
average of ~5% per year since the mid-90’s, with large peaks of infection occurring every ~3.5 
years (Fig. 2a and Fig. S7 in SI). The increasing probability of natural infection over time, 
together with the absence of exposure-free periods, suggests that CPV is likely to be maintained 
in the domestic dog population. Note that dog sampling started in 1992 but, albeit with high 
uncertainty, our model back-predicts the probability of infection from 1984, when the oldest 
dog was born.  
 
Vaccination coverage determined from the number of dogs vaccinated provided an 
underestimation of the true proportion of dogs in the population exposed to CPV vaccine. Our 
model estimated that post-2003, when vaccination coverage was highest, vaccine shedding 
contributed an average of 10.6% to the probability of domestic dogs being seropositive (Fig. 
2a, red line). This increase corresponded to ~19.3% of the village vaccination coverage (Fig. 
3a).  
 
Our results show that vaccination can decrease the probability of natural CPV infection in 
domestic dogs, but efforts during the study period were not high enough to eliminate infection 
even considering the indirect additional exposure provided by vaccine shedding. By comparing 
the predicted annual probability of infection from the full model with that predicted without 
vaccination (Fig. 3b), our results show that there was no measurable impact of dog vaccination 
on the probability of infection when regional vaccination efforts were patchier (pre-2003). 
However, following intensification of the vaccination effort in 2003, dog vaccination decreased 
the predicted annual probability of infection. For example, in 2008 when vaccination effort 
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was the highest (~30%), the predicted annual probability of infection was ~10% lower than 
that predicted without vaccination. Since there was a continued increase in CPV prevalence 
over time, these results indicate that vaccination was likely working to slow down the rate of 
CPV prevalence increase. 
 
CPV dynamics at the domestic-wildlife interface 
The estimated mean annual probability of CPV infection in lions was low (~9%; Fig. 2b). We 
note that this estimate was considerably lower than the observed mean seroprevalences (Fig. 
1b) because it takes into account sample size and the timing of infection of each individual, 
which the observed seroprevalence does not.  
 
The time between peaks of CPV infection in dogs and lions was ~3.5 years (Fig. 2 and S8 in 
SI) resulting in a pattern of peaks of infection in dogs preceding those in lions by one year. In 
support of this observation, our model showed a strong positive influence of the probability of 
natural infection in dogs on that in lions, as estimated from the dog-to-lion cross-species 
transmission parameter (mean 1.04 and 95% CI = [0.021, 3.78]; Fig. 4). In contrast, the model 
estimated only a negligible influence of the probability of infection in lions on that in dogs 
(mean 0.11 and 95% CI = [0.0030,0.40], Fig. 4). However, sample sizes in lions were small 
and the credible intervals on the associated predictions were too wide to accurately quantify 
the factual increase in the probability of infection in lions driven by dogs (Table S1).  
 
CPV infection in lions does not seem endemic since lions had at least four distinct population-
wide peaks of infection between 1980 and 2012, each following a period when infection in the 
lions was absent (Fig. 2b). These observations are supported by age-seroprevalence curves 
(Fig. S8 in SI). Together with the lagged but coupled peaks of infection in lions, our findings 
suggest that domestic dogs are integral to the maintenance of CPV infection in the Serengeti 
ecosystem and that lions alone do not maintain CPV. 
 
CPV and CDV co-exposure patterns in domestic dogs 
We found evidence of CPV and CDV co-exposure in domestic dogs. From the 1728 dogs for 
which we had a serology result for both CPV and CDV, 51.3% (n=887) were positive for CPV 
and 7.4% (n=128) for CDV. This is in agreement with the average seroprevalence (Fig.1b) 
observed and is consistent with previous studies on CDV in the same system [9]. The 110 dogs 
that were co-exposed to CPV and CDV correspond to 6.4% of the total number of individuals, 
as shown in the Venn diagram (Fig. 5a). However, if infection from these two diseases occurs 
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independently, the probability of co-exposure by both viruses - estimated as the product of the 
estimated probabilities for each one of them - would be 3.8%, which corresponds to 68 dogs, 
i.e. we observe 1.62 times more co-exposed dogs than expected by chance. This 
overrepresentation of dogs infected by both viruses suggests that CDV and CPV infection 
patterns are not independent of each other as confirmed by a chi-squared independence test (p-
value=8.3e-16).  
 
Our model results provide further evidence of an interaction between CPV and CDV in 
domestic dogs and indicates that CPV infection might increase the probability of CDV 
infection. Fig. 5b shows the estimated posterior distribution of the parameters describing the 
probability of co-exposure (pboth). The posterior for Gboth, which quantifies the independence of 
CPV and CDV on the probability of being co-exposed, was estimated to be 71% (95% CI= [-
4.50,7.05]) above zero (Fig. 5b). This supports the observation that exposure to these two 
pathogens is not occurring purely independently. In contrast, the parameters GCDV, which 
quantifies the influence of being infected with CDV and GCPV, which corresponds to the 
influence of CPV on the probability of being co-exposed, were estimated as 87% (95% CI= [-
1.30,8.17]) and 99.9% (95% CI= [0.67,9.04]) positive, respectively (Fig. 5b). This suggests 
that co-exposure could be driven by either pathogen but it is more likely that CPV infection 
makes an individual more prone to CDV infection. 
 
Another line of evidence comes from the difference between the predicted dynamics of pboth 
without the influence of CDV (or CPV) and the full prediction (Fig. 6) in domestic dogs. If 
CDV or CPV drive co-exposure this difference will always be negative. Our results show that 
until ~2003 the difference in both cases is generally negative. However, from 2003, the 
difference between predicted dynamics with and without CPV or CDV increases substantially 
(Fig. 6). This suggests that the increase in vaccination effort which occurred at this time, might 
have acted to decouple the co-infection processes. 
 
 
Discussion  
 
This study used Bayesian state-space models to investigate the transmission ecology of CPV 
in the Serengeti ecosystem, a multi-pathogen system at the domestic-wildlife interface. We 
found endemic CPV circulation with a mean probability of infection at least 2 times higher in 
dogs than in lions. Dog vaccination reduced the rate of increase of CPV prevalence in dogs, 
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but the vaccination coverage achieved did not eliminate or stabilise CPV circulation in the 
western part of the Serengeti ecosystem, even with additional “protection“ of unvaccinated 
dogs occurring as a result of vaccine virus shedding.  Our findings further suggest that cross-
species transmission of CPV largely occurs in one direction, from dogs to lions, and that peaks 
of CPV incidence in lions follow those in dogs. This is consistent with the hypothesis that dogs 
are a maintenance population and a source of CPV infection for lions. Periodic outbreaks of 
other canine viruses such as CDV have been previously reported in this complex system [9]. 
Here, we found that CPV infection might have made dogs more prone to CDV infection, but 
that more recent (higher) vaccination levels could have weakened this coupling. 
 
In the Serengeti ecosystem, it is unclear whether CPV was circulating in dogs until mid’90s 
but it has since rapidly increased to become widespread and endemic in dogs. This suggests a 
high force of infection and raises questions about the role of the multiple possible transmission 
routes of CPV. In addition to the common faecal-oral route of transmission from fresh faeces 
[23], it has also been suggested that the virus can be transmitted after some time from the 
environment [22,60]. However, the lack of stable endemic infection, as evidenced by periodic 
peaks of infection in dogs and periods when CPV infection is absent in lions, as well as the 
coupling of infection in lions with infection in dogs are not entirely consistent with long-term 
environmental persistence. If environmental persistence does not occur, and with little 
evidence for an external force of infection in this system, control of CPV through vaccination 
could be possible. Although our findings show that CPV vaccination can reduce the probability 
of infection in dogs, consistent and higher coverage is needed to counteract the high prevalence 
observed.  
 
Cross-species transmission of CPV between domesticated and wild animals is a widespread 
phenomenon [41,62]. We show for the first time that CPV infection cycles in lions might be 
coupled with those in dogs, but lag by one year. Together with evidence for unidirectional 
cross-species transmission from dog to lions, this strongly suggests that dogs act as a source of 
infection for lions and that lions are not maintaining CPV infection independently of dogs. 
Although domestic dogs and lions rarely have direct interactions, there are numerous other 
carnivore species that could act as intermediate hosts [63]. Phylogenetic information about 
CPV in the Serengeti ecosystem might help disentangle long-term cross-species jumps and 
clarify the origins of CPV in this system.  
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Additional complexity arises because CPV and FPV are antigenically very similar [64,65], 
which makes these two pathogens difficult to distinguish serologically. It is therefore possible 
that some of the lion CPV seropositives in this study arise from infection with FPV. Recent 
genetic analysis indicated that there is an independent FPV cycle in the Serengeti lions that 
was not dependent on domestic dogs [46] and did not detect CPV DNA in any of the lions 
tested (6 FPV positives from 44 samples). It is possible that, compared to FPV which seems to 
remain as a persistent infection within individuals, cycles of infection of CPV in wildlife are 
short-lived with virus being cleared or host animals dying as a result of disease. Our hypothesis 
that there is a CPV cycle in lions is supported by the coupling of peaks in seropositivity in lions 
and dogs, which suggests that infection processes are linked, with dogs a likely source of CPV 
infection for lions. Although it is possible that this temporal relationship is coincidental, if FPV 
infection was the only explanation for the observed CPV seropositivity in lions, more stable 
patterns of lion seropositivity would be expected across time, yet distinct peaks of infection are 
evident.  
 
The lack of coupling of CDV with CPV peaks of infection in dogs suggests that the two viruses 
can circulate independently from one another. This is not surprising as both viruses are 
widespread with different routes of transmission [29,54]. Nonetheless, we found evidence of 
interactions between these two pathogens, although it remains unclear which pathogen 
facilitates co-infection dynamics in dogs. The mechanisms driving co-exposure to CDV and 
CPV are unknown, however we suggest three reasons that might explain the dynamics 
observed: First, there could be different survival rates of hosts infected by CPV or CDV, rather 
than contemporaneous coinfection. However, in non-equilibrium systems, the mortality rates 
associated with these diseases are difficult to infer. Second, it is well established that these 
diseases weaken the immune system [66] leaving individuals more susceptible to other viruses. 
Third, these viruses could have common risk factors. For example, CPV can cause brain 
pathology, especially in puppies [67], leading to behavioural changes such as anxiety or 
aggression triggered by fear, which could increase the probability of high-risk contacts with 
other dogs. There may not be a single explanation for the co-exposure patterns we observe and 
potential interdependencies could be difficult to disentangle. However, these hypotheses 
provide intriguing avenues for future research.   
 
Targeting the maintenance population can be an effective way to manage disease with potential 
for elimination [1,3]. Dog vaccination could help limit CPV transmission within the Serengeti 
ecosystem but elimination is likely to be challenging. Village vaccination coverage reached at 
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most 56%, but the regional vaccination coverage was ~30%. This level of coverage has not 
been sufficient to prevent an increase in CPV circulation in this system, even with the potential 
increase in coverage from immunity acquired from vaccine shedding. However, this level of 
coverage could have altered the disease dynamics through decoupling CDV from CPV 
dynamics. Further research is needed to confirm disease decoupling driven by vaccination and 
whether targeting a single disease would have been sufficient for this decoupling. Studies from 
other systems have shown that vaccination can alter dynamics of co-infections either 
negatively, for example by decreasing the immune reactivity to a vaccine against a second 
disease [68], or positively, by increasing the efficacy of the vaccine against a second disease 
[69]. Our co-exposure time series ends at the peak of vaccination effort. Further studies will be 
required to fully understand the role of vaccination in CPV and CDV coinfection dynamics and 
the importance of this decoupling to this system or for other co-infections. This highlights the 
importance of considering the joint dynamics of multiple pathogens. 
 
Longitudinal serology from two host species combined with powerful statistical approaches 
provide insights into the within-host species disease dynamics of two pathogens and between-
host species dynamics of one pathogen circulating among wildlife and domestic animals. 
Further, our statistical methods allowed, for the first time, analysis of CPV serological data that 
incorporated exposure from vaccine virus shedding. It is clear that understanding the dynamics 
of such complex multi-host, multi-pathogen systems is important but challenging, given the 
difficulties of directly measuring infection processes. Cross-species transmission and co-
infection are only two of several factors affecting disease dynamics. Establishing 
(dis)similarities in epidemiological dynamics in single infection versus co-infection and single-
host versus multiple host species scenarios offer exciting opportunities for designing improved 
interventions strategies. Within the context of our study system there might be implications for 
vaccine development as there are currently no monovalent vaccines available for CDV and 
CPV. Although there are no additional costs of vaccinating against CPV, the pathogen is now 
widespread in the Serengeti ecosystem, which raises the question of the need for continued 
vaccination at current levels. Nonetheless, whether increased vaccination levels might be able 
to reverse the observed endemic circulation in dogs remains unknown and, if confirmed, the 
decoupling of the two infections as a result of vaccination could justify maintaining the 
vaccination programme, even at current levels. 
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FIGURES 
 
 
Figure 1: Data used in this study. a) Sampling locations of domestic dogs (grey circles) and 
lions (blue circles) in the Serengeti ecosystem. The Serengeti National Park (SNP) is shown in 
the dark grey shaded area. b) Observed annual seroprevalence of CPV in domestic dogs (grey) 
and African lions (blue) and of canine distemper virus (CDV; green) in dogs. The orange dotted 
line corresponds to the regional vaccination coverage. Sample sizes available in Table S1 (SI). 
 
Figure 2: Estimated CPV temporal profiles. a) Mean annual probability of CPV natural 
infection (grey) and vaccine-shed (red) seropositivity in domestic dogs, and village vaccination 
coverage (orange dotted line). b) Mean annual probability of CPV infection in lions. Associated 
50%, 75% and 95% credible intervals shown in increasingly lighter colour shading. Vertical 
dotted line corresponds to year 2003, the start of larger vaccination efforts. 
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Figure 3: Effects of vaccination. a) Posterior distribution of the parameter describing the 
influence of shedding (j in eq.1). b) Mean difference between the estimated prediction of the 
annual probability of CPV infection and that without the vaccination effect (black). This 
difference is negative if vaccination reduces the probability of CPV infection. Associated 50%, 
75% and 95% credible intervals shown in increasingly lighter colour shading. Annual village 
vaccination coverage shown in orange. Inset, the posterior distribution of the parameter 
describing the influence of vaccination on the annual probability of dog infection (v1).  
 
 
Figure 4: Cross-species transmission of CPV. Posterior distributions of the parameters 
describing the influence of the probability of infection of dogs on that of lions (ΩDL; grey) and 
vice-versa (ΩLD; blue).  
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Figure 5: Co-exposure patterns. a) Venn Diagram representing the number of dogs exposed 
to CPV (light grey) and CDV only (intermediate grey) and co-exposed with both diseases 
(dark grey). b) Posterior distributions of the parameters describing the influence of CPV 
(dotted line) and CDV (dashed line) only, and that of both diseases if they are independent 
(pCPV*pCDV; solid line) on the co-exposure (pboth) dynamics. 
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Figure 6: Influence of CPV and CDV on co-exposure. Difference between the predicted annual 
probability of being co-exposed to CPV and CDV, and that without the effect of CDV (dotted 
line) and CPV (dashed line). This difference is negative if shutting down the effect of one 
pathogen reduces the probability of co-exposure. Shaded area corresponds to the back-
predicted period. 
